Randomized Phase II Trial of Letrozole plus Anti-MUC1 Antibody AS1402 in Hormone Receptor-Positive Locally Advanced or Metastatic Breast Cancer von IBRAHIM, Nuhad K, YARIZ, Kemal O, SENDEROVICH, Shai, CHAU, Albert, ERLANDSSON, Fredrik, ACTON, Gary, PEGRAM, Mark, BONDARENKO, Ihor, MANIKHAS, Alexei, SEMIGLAZOV, Vladimir, ALYASOVA, Anna, KOMISARENKO, Volodymyr, SHPARYK, Yaroslav, LEE MURRAY, James, JONES, David

Volltext

Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype von MILYAVSKY, Michael, SHATS, Igor, ROTTER, Varda, EREZ, Neta, XIAOHU TANG, SENDEROVICH, Shai, MEERSON, Ari, TABACH, Yuval, GOLDFINGER, Naomi, GINSBERG, Doron, HARRIS, Curtis C

Volltext

Abstract 3665: The novel DNA intercalator amonafide (AS1413), disrupts the cell cycle by mechanisms distinct from those of Topo II inhibitors daunorubicin and etoposide von Senderovich, Shai, Jones, David, Ajami, Alfred, McLaughlin, Fiona

Volltext

Abstract 3647: Gene expression analysis in AML cell line MV4-11 following treatment with the anti-cancer aptamer AS1411 von Senderovich, Shai, Ajami, Alfred, Doran, Ben, McLaughlin, Fiona, Jones, David

Volltext

Activation of p53 protein by telomeric (TTAGGG)n repeats von Milyavsky, M, Mimran, A, Senderovich, S, Zurer, I, Erez, N, Shats, I, Goldfinger, N, Cohen, I, Rotter, V

Volltext